• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MAQUET CARDIOPULMONARY GMBH TUBING SET; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MAQUET CARDIOPULMONARY GMBH TUBING SET; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Model Number HLS SET
Device Problems Crack (1135); Fluid/Blood Leak (1250)
Patient Problem Insufficient Information (4580)
Event Date 01/08/2024
Event Type  Injury  
Manufacturer Narrative
A follow-up medwatch will be submitted when additional information becomes available.H3 other text : device already discarded by customer.
 
Event Description
It was reported that there was a blood leak and one of the 3 stopcocks has a crack on the bottom.The failure occurred during treatment.The consequence for the patient is a loss of hemoglobin of 7.5 tp 6.7 g/dl.This required the provision of cgr.The hls set was discarded by the customer.Complaint id# (b)(4).
 
Manufacturer Narrative
It was reported that there was a blood leak and the valve has a crack on the bottom.The failure occurred during treatment.The consequence for the patient is a loss of hemoglobin of 7.5 tp 6.7 g/dl.This required the provision of a transfusion.The hls set was exchanged.The hls set was discarded by the customer.Further it was reported that the affected hls set was initially used for four days without any malfunction.On 2024-02-22 the information was received that the customer will not provide further information.A medical review was performed by getinge medical affairs on 2024-03-08 with following conclusion: "the very sparse complaint narrative describes the development of a leak, presumably at one of the luer-lock connectors on the hls-set intended for blood sampling ("quick vent" luer lock connector, luer lock connector "arterial sampling", "venous sampling" luer lock connector).The answers provided to the questions posed by the dcu to the customer could not identify the exact site of the leak.As the french ¿robinet¿ can be translated into various synonyms for closable apertures, it might exclude the true-bored luer-connectors present on the hls-module.The answer to the question ¿was the crack on the three-way valve?¿ suggests that a three-way-stopcock by another supplier may have been utilized.The answer: ¿not on the 3 way faucet, the faucet had a crack on the lower part.¿ suggests the damage may have been to the hls-housing at the luer-connector.Regardless, the customer¿s responses appear to disagree with each other, leading to difficulty arriving at a clear determination of the origin of the nonconformance given the limited information provided.Assuming the defect to be present on the threaded female luer-connector of the hls module, it is unlikely that the defect was present from the beginning of support, as the set is checked, handled and monitored by the user during, set-up, priming and implantation, where a leak would have been detected.In the chapter 5.2 ¿safety instructions for the extracorporeal circulation¿, the hls-set ifu instructs the user to secure and check all connections and components before and during use.High torque/tension may have been applied unintentionally during fastening of the male-luer connector to the disposable.This is also possible during routine checks of the circuit by ¿re-tightening¿ or upon sudden/inadvertent tension exerted if lines are pulled during use.Given the assumption that the intra-system pressures and mechanical strain applied to the disposable are relatively constant during extracorporeal support, the development of a crack at the housing may be explained by the exertion of force onto the disposable sometime on day four.The accumulation of leaked blood then was detected and led to the exchange of the damaged hls-set.The dearth of information and the discarded disposable prohibits a further investigation into the exact position, nature, and/or origin of the defect.In conclusion, a definitive root cause could not be established given the available information.Further, considering the delay of 72-96 hours for the development or detection of the leak, a reasonable supposition may be that the product may have been damaged unintentionally during support while the product was used as a platform for continuous renal replacement therapy.Last, the blood lost by the patient which required the administration of packed red blood cells may have been associated to the event reported in the complaint; however, the severity (in terms volume lost) and duration of the leak, the disposition of the patient, and the details regarding the conduct of extracorporeal support are all unknown.Therefore, a clear determination of an association between the reported leak and the administration of packed cells cannot be established at the time of this review." referring to the instructions of use of the hls set (chapter basic safety instructions) it is stated to not use defective devices (example if device is damaged).In chapter ¿safety instructions for the hls set¿ it is further mentioned to check the set if its complete and not defective.Further chapter "preparation and installation" states to perform a careful visual inspection of the sterile packaging before use and to pay particular attention to moisture, openings and soiling.Additionally a careful visual inspection of the device before use should be performed.In particular, to ensure there is no damage to the material, cracks, burrs or fissures.¿ the production records of the affected product were reviewed on 2024-03-08.According to the final test results, the product passed the tests as per specifications.Production related influences are unlikely.Based on the results the reported event "leakage - due to crack, patients hemoglobin low" could not be confirmed due to affected product was not made available for investigation and due to not providing all information by the customer.The customer will be informed about the results by the getinge sales and service unit.The occurrence rate was calculated for the reported issue and it was determined that this is not a systemic issue.Therefore, no remedial action is required.The occurrence rate related to the reported issue is currently being monitored as part of maquet cardiopulmonary¿ s trending program and additional investigations or corrections will be implemented in case of adverse trending.
 
Event Description
Complaint id# (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TUBING SET
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
MAQUET CARDIOPULMONARY GMBH
neue rottenburger strasse 37
hechingen
Manufacturer (Section G)
JULIA KAPFENBERGER
neue rottenburger strasse 37
hechingen
Manufacturer Contact
neue rottenburger strasse 37
hechingen 
MDR Report Key18510119
MDR Text Key332895297
Report Number8010762-2024-00023
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K112360
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 03/13/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/15/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberHLS SET
Device Catalogue Number701069073
Device Lot Number3000336489
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/08/2024
Was Device Evaluated by Manufacturer? No
Date Device Manufactured08/28/2023
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Life Threatening;
-
-